EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases

Anke S Lonsdorf, Dominic Edelmann, Thomas Albrecht, Alexander Brobeil, Jannik Labrenz, Moritz Johanning, Richard F Schlenk, Benjamin Goeppert, Alexander H Enk, Ferdinand Toberer

Acta Dermato-Venereologica · 2024

DOI: 10.2340/actadv.v104.13381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2024. Verfasst von Anke S Lonsdorf und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany. anke.lonsdorf@med.uni-heidelberg.de. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Keratoacanthoma, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beyond established anti-programmed cell death protein 1/programmed cell death ligand 1 immunotherapy, T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain (TIGIT) and its ligand CD155 are promising novel inhibitory immune checkpoint targets in human malignancies. Yet, in cutaneous squamous cell carcinoma, evidence on the collective expression patterns of these inhibitory immune checkpoints is scarce. Complete tumour sections of 36 cutaneous squamous cell carcinoma, 5 cutaneous metastases and 9 keratoacanthomas, a highly-differentiated, squamoproliferative tumour, with disparately benign biologic behaviour, were evaluated by immunohistochemistry for expression of programmed cell death ligand 1 (Tumor Proportion Score, Immune Cell Score), TIGIT, CD155 and CD8+ immune infiltrates. Unlike keratoacanthomas, cutaneous squamous cell carcinoma displayed a strong positive correlation of programmed cell death ligand 1 Tumor Proportion Score and CD115 expression (p < 0.001) with significantly higher programmed cell death ligand 1 Tumor Proportion Score (p < 0.001) and CD155 expression (p < 0.01) in poorly differentiated G3-cutaneous squamous cell carcinoma compared with keratoacanthomas. TIGIT+ infiltrates were significantly increased in programmed cell death ligand 1 Immune Cell Score positive primary tumours (p = 0.05). Yet, a strong positive correlation of TIGIT expression with CD8+ infiltrates was only detected in cutaneous squamous cell carcinoma (p < 0.01), but not keratoacanthomas. Providing a comprehensive overview on the collective landscape of inhibitory immune checkpoint expression, this study reveals associations of novel inhibitory immune checkpoint with CD8+ immune infiltrates and tumour differentiation and highlights the TIGIT/CD155 axis as a potential new target for cutaneous squamous cell carcinoma immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellKeratoacanthomaSkin NeoplasmsHumansImmune Checkpoint ProteinsLigandsReceptors, Immunologic

Substanzen

Immune Checkpoint ProteinsLigandsReceptors, Immunologic

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany. anke.lonsdorf@med.uni-heidelberg.de.
  • German Cancer Research Center, Heidelberg, Germany; NCT Trial Center, National Center for Tumor Diseases, German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.
  • Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; Tissue Bank of the National Center for Tumor Diseases, Heidelberg, Germany .
  • Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; Institute of Pathology and Neuropathology, RKH Klinikum Ludwigsburg, Germany.
  • Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.

Zitieren

APA

Lonsdorf, A. S., Edelmann, D., Albrecht, T., Brobeil, A., Labrenz, J., Johanning, M., Schlenk, R. F., Goeppert, B., Enk, A. H., & Toberer, F. (2024). Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v104.13381

Vancouver

Lonsdorf AS, Edelmann D, Albrecht T, Brobeil A, Labrenz J, Johanning M, et al. Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases. Acta Dermato-Venereologica. 2024. doi:10.2340/actadv.v104.13381

BibTeX
@article{Lonsdorf2024,
  author = {Lonsdorf, Anke S and Edelmann, Dominic and Albrecht, Thomas and Brobeil, Alexander and Labrenz, Jannik and Johanning, Moritz and Schlenk, Richard F and Goeppert, Benjamin and Enk, Alexander H and Toberer, Ferdinand},
  title = {Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases},
  journal = {Acta Dermato-Venereologica},
  year = {2024},
  doi = {10.2340/actadv.v104.13381}
}
Kostenlos starten →